Back

Relationship between proprotein convertase subtilisin/kexin type 9 (PCSK9) and thrombotic events in primary antiphospholipid syndrome. The multicenter ATHERO-APS study.

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Autoimmune/chronic inflammatory disorders and heart disease 2 Autoimmune/Chronic Inflammatory Disorders and Heart Disease ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Tommaso Bucci

University of Perugia, Perugia (Italy)

5 More presentations in this session

Presentation thumbnail
Association between cumulated hydroxychloroquine in systemic lupus erythematosus and development of cardiac conduction alterations
Doctor J. Zubiaur Zamacola (Madrid, ES)
Abstract Slides
Presentation thumbnail
Incidence and impact of venous thromboembolism in hospitalized patients with Crohn-disease
Doctor K. Keller (Mainz, DE)
Abstract Slides
Presentation thumbnail
Biologics improve endothelial, vascular and left ventricular myocardial function in patients with psoriatic arthritis
Doctor I. Ikonomidis (Athens, GR)
Abstract Slides
Presentation thumbnail
Prevalence of abnormal left ventricular geometry and predictors of left ventricular hypertrophy in patients with rheumatoid arthritis
Doctor T. Nilmoje (Hat Yai, TH)
Abstract Slides
Presentation thumbnail
A nationwide analysis of cardiac sarcoidosis and related in-hospital outcomes
Doctor V. Victor (Canton, US)
Abstract Slides

Access the full session

Session thumbnail
Autoimmune/chronic inflammatory disorders and heart disease 2

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources